Even slurs against the gay community only appeared in the third paragraph, mentioned in a single sentence.
Regarding the latter, see also the discussion below (Background section) on this.Reviewer comments:Background· The second paragraph mentioning the protein-protein interactions network example is not totally relevant to the gene expression analysis yet it is described in length.
Introduction: In the first paragraph you mentioned that 2 strains of A. marina have been well described, but then proceed to describe only one (MBIC11017).
Either in the same paragraph or a brief second paragraph, mention any other details that might be relevant.
(Remember that horse in the first paragraph? Did I mention that it was white?) He wields his camera with a heavy hand, punctuating nearly every scene with emphatic nods, smiles or grimaces as the occasion requires.
The first paragraph of the article mentioned psychiatric disorders and in the second paragraph, they also note that, "The Iraq war veteran was being evaluated for post-traumatic stress disorder".
Given that in each granule cell receives input from approx. 4 MFBs, independent of the behavioural state, one would expect a ratio of approx. 1 4 (as reported in the first paragraph of the above mentioned subsection).
In the second paragraph he mentions his relationship to Daniel Pearl.
In the third paragraph, when mentioning that the PHiD-CV vaccine is a worth-while alternative to the pneumococcal conjugate vaccine PCV13, the authors should add: … in children younger than 5 years of age.
In the second paragraph, when mentioning that the PHiD-CV vaccine is currently licensed in more than 125 countries, the authors should make clear that the vaccine is licensed for active immunization against invasive disease, pneumonia, and acute otitis media (AOM) caused by S. pneumoniae in infants and young children up to 5 years of age.
I have only minor comments: In the second paragraph, when mentioning that the PHiD-CV vaccine is currently licensed in more than 125 countries, the authors should make clear that the vaccine is licensed for active immunization against invasive disease, pneumonia, and acute otitis media (AOM) caused by S. pneumoniae in infants and young children up to 5 years of age.
